MAINSTREAM

The MAINSTREAM EPSRC research and partnership hub between University of Glasgow, University of Strathclyde, University of Nottingham and UK National Health Service working to develop health technologies in Manufacturing Stem Cells for Regenerative Medicine, Immunotherapy and Cancer, making MSC therapies a reality in the UK and around the world.  We have developed materials that tell MSCs to remain as stem cells, proliferate for longer, to retain their immunomodulatory and regenerative properties and not to age or differentiate in culture.  In the hub, we will link these materials and understanding to non-invasive characterisation and manufacturing technologies, so that we can scale-up our materials to an industrial level and study cell phenotype as they grow.  The hub, and the UK leadership it will provide, will unlock the huge potential of these stem cells to give us not simply more years of life, but years of higher quality life.

For further information, please visit https://www.mainstream-hub.org/